KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Inventory (2016 - 2026)

Medtronic's Inventory history spans 12 years, with the latest figure at $6.3 billion for Q1 2026.

  • For Q1 2026, Inventory rose 12.46% year-over-year to $6.3 billion; the TTM value through Jan 2026 reached $6.3 billion, up 12.46%, while the annual FY2025 figure was $5.5 billion, 4.96% up from the prior year.
  • Inventory for Q1 2026 was $6.3 billion at Medtronic, up from $6.2 billion in the prior quarter.
  • Across five years, Inventory topped out at $6.3 billion in Q1 2026 and bottomed at $4.5 billion in Q1 2022.
  • The 5-year median for Inventory is $5.5 billion (2025), against an average of $5.4 billion.
  • The largest annual shift saw Inventory grew 19.07% in 2023 before it fell 4.78% in 2024.
  • A 5-year view of Inventory shows it stood at $5.1 billion in 2022, then grew by 13.83% to $5.8 billion in 2023, then dropped by 4.78% to $5.5 billion in 2024, then rose by 12.36% to $6.2 billion in 2025, then rose by 2.49% to $6.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Inventory are $6.3 billion (Q1 2026), $6.2 billion (Q4 2025), and $5.9 billion (Q3 2025).